TOVX Latest Press Releases

-- February 3, 2026 --

Theriva Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026 Globe Newswire 8:00 AM

-- December 29, 2025 --

Theriva Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Globe Newswire 8:00 AM

-- November 12, 2025 --

Theriva Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results Globe Newswire 8:00 AM

-- October 24, 2025 --

Theriva Biologics Provides Response to Unusual Market Action Globe Newswire 2:31 PM

-- October 16, 2025 --

Theriva Biologics Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds Globe Newswire 8:11 AM

-- October 13, 2025 --

Theriva Biologics Announces Upcoming Presentations at Medical Meetings Globe Newswire 8:00 AM

-- October 6, 2025 --

Theriva Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT) Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software